中文FrançaisDeutsch日本語Русский языкEspañolعربيEsperanto한국어BIG5
CHINA DEVELOPMENT GATEWAY
SiteMap Feedback
Travel Living in China Archaeology Film Learning Chinese Chinatown Suppliers
Home China International Business Government Education Environment Culture Women Books & Magazines Sports Health Entertainment
Home / China / National News Tools: Save | Print | E-mail | Most Read
Hepatitis B Vaccine Undergoes Second Clinical Tests
Adjust font size:  ZoomIn ZoomOut

The second phase of clinical tests of China's hepatitis B vaccine are being carried out on 46 chronic hepatitis B patients to test the vaccine's effectiveness, according to expert Wu Yuzhang.

The patients began treatment in June and will remain under close medical observation until the tests end next March, said Wu, head of the Immunology Institute of the People's Liberation Army.

The research team headed by Wu completed the first phase of clinical test of the vaccine in June 2003. Nine months of monitoring proved that the tests are safe for humans.

52 healthy volunteers are taking part in the tests.

"The vaccine needs to go through a third phase of clinical tests before being put into production. The third phase of tests will be conducted on a larger group of hepatitis B patients to test safety and effectiveness," Wu said.

It is estimated that about 100 million Chinese are living with hepatitis B and about 20 million of them are chronic hepatitis B patients. Each year in China about 280,000 people die of cirrhosis or liver cancer linked to hepatitis B. Globally, about 350 million people are infected with hepatitis B.

Wu said the hepatitis B global inoculation scheme being promoted by the World Health Organization is based on a preventive vaccine, which has no effect on infected people and fails to protect five to 15 percent of newborns. So far, no vaccine has succeeded in killing the virus in the patient's body, he said.

Li Lanjuan, a researcher with the Chinese Academy of Engineering, said at a recent medical forum that current hepatitis B vaccines have no effect on about five percent of receivers, and cannot kill the virus completely.

Wu said China has full intellectual property rights over the new vaccine.

China has recently stepped up efforts to raise public awareness of the disease. The Chinese Foundation for Hepatitis Prevention and Control has invited Andy Lau, a famous Hong Kong star, who is carrying the hepatitis B virus, to be a publicity ambassador for the prevention and control of the disease.

The Chinese Ministry of Health has begun a year-long nationwide survey of the hepatitis B situation, in order to update data and guidelines on prevention and control of the disease.

(Xinhua News Agency October 26, 2006)

Tools: Save | Print | E-mail | Most Read

Related Stories
Hepatitis B Therapeutic Vaccines Start Clinical Trials
Chinese Doctors Urge Better Awareness on Hepatitis B Disease
Chinese, US Agencies Help Hepatitis B Prevention
Infectious Disease Outbreaks Reported
Clear Evidence of Progress in Hepatitis B Campaign
SiteMap | About Us | RSS | Newsletter | Feedback
SEARCH THIS SITE
Copyright ? China.org.cn. All Rights Reserved ????E-mail: webmaster@china.org.cn Tel: 86-10-88828000 京ICP證 040089號
主站蜘蛛池模板: 国产精品视频免费一区二区三区 | 狠狠色狠狠色综合网| 国产午夜手机精彩视频| 中文字幕激情视频| 欧美黑人xxxx又粗又长| 十八岁污网站在线观看| 青娱乐在线视频播放| 女人18特级一级毛片免费视频| 久久99精品国产一区二区三区| 暖暖免费高清日本中文| 亚洲女人初试黑人巨高清| 淫444kkk| 你懂的电影在线| 精品久久久久久亚洲综合网| 四虎国产在线观看| 色婷婷综合在线| 国产免费女女脚奴视频网| 91香蕉视频黄色| 天天操夜夜操视频| 久久精品视频免费看| 男人j桶进女人p无遮挡在线观看 | 国产麻豆videoxxxx实拍| aaa毛片视频免费观看| 日韩大片高清播放器| 亚洲老妈激情一区二区三区| 精品一区二区三区在线播放视频| 啦啦啦手机完整免费高清观看 | 精品日韩在线视频一区二区三区| 国产精品一区二区欧美视频| 97精品免费视频| 成年网址网站在线观看| 久久久久久综合| 日本免费人成视频播放| 久久国产精品免费网站| 日本黄色免费观看| 久久精品国产精品| 日韩在线视频网址| 久久精品一区二区三区四区| 日韩在线第二页| 久久只有这里的精品69| 日本强伦姧人妻一区二区|